The pace of change in drug discovery and clinical development has been unmatched in recent years, with technologies such as AI accelerating these processes.
Every patient, every doctor or nurse, every hospital worker is a human being influenced by their experiences outside of healthcare. In the consumer world, we have all come to expect speed and inter
Healthcare’s digital revolution has been transformed into a digital evolution over the last decade and, having redefined the way healthcare operates, it continues to refine the provision of
Bristol-Myers Squibb’s hopes of adding a new indication to the label for S1P modulator Zeposia have been dented after the drug failed a phase 3 trial in Crohn’s disease.